Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4530851000168119 | Ibrance (palbociclib 125 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4530861000168117 | Ibrance 125 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibrance 125 mg tablet | Is a | palbociclib 125 mg tablet | true | Inferred relationship | Some | ||
| Ibrance 125 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ibrance 125 mg tablet | Is a | Ibrance | true | Inferred relationship | Some | ||
| Ibrance 125 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Ibrance 125 mg tablet | has Australian BoSS | palbociclib | true | Inferred relationship | Some | 1223117342 | |
| Ibrance 125 mg tablet | has intended active ingredient | palbociclib | true | Inferred relationship | Some | 1223117342 | |
| Ibrance 125 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 841841844 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ibrance 125 mg tablet, 21 | has TPUU | True | Ibrance 125 mg tablet | Inferred relationship | Some | 968273532 |
| Ibrance 125 mg tablet, 21, blister pack | has TPUU | True | Ibrance 125 mg tablet | Inferred relationship | Some | 727524606 |
Reference Sets
Trade product unit of use reference set
FHIR